GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE
Clinical trials for GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Vitamin B3 shows promise in brain cancer fight
Disease control TerminatedThis study looks at adding a high-dose form of niacin (vitamin B3) to the usual treatment for people newly diagnosed with a fast-growing brain cancer called glioblastoma. The goal is to find a safe dose and see if it helps patients live longer without their cancer growing. About …
Matched conditions: GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 26, 2026 08:03 UTC
-
New mRNA vaccines aim to stop brain cancer comeback
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests two mRNA vaccines, GV-108 and GV-907, in 9 adults with a specific type of brain cancer (IDH-wildtype glioblastoma). The goal is to see if the vaccines are safe and can trigger the immune system to fight the cancer, potentially preventing it from comin…
Matched conditions: GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE
Phase: EARLY_PHASE1 • Sponsor: Beijing Neurosurgical Institute • Aim: Disease control
Last updated May 20, 2026 12:08 UTC